A Practical Synthesis of the TGFβRI Inhibitor N-(4-(3-(6-(Difluoromethyl)pyridin-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)pyridin-2-yl)acetamide via One-Pot Sequential Sonogashira and Cacchi Reactions Catalyzed by Pd(OAc)2/BINAP

被引:4
|
作者
Li, Jianqing [1 ]
Smith, Daniel [2 ]
Krishnananthan, Subramaniam [2 ]
Mathur, Arvind [2 ]
机构
[1] Bristol Myers Squibb Res & Dev, Small Mol Drug Discovery, Cambridge, MA 02142 USA
[2] Bristol Myers Squibb Res & Dev, Small Mol Drug Discovery, Princeton, NJ 08543 USA
关键词
TGF beta RI; Sonogashira; Cacchi; one-pot; 4-azaindole; 2,3-DISUBSTITUTED INDOLES; REGIOSPECIFIC SYNTHESIS; COUPLING REACTION; FUNCTIONALIZATION;
D O I
10.1021/acs.oprd.0c00015
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
4-(3-(6-(DifluoromethyOpyridin-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl)pyridin-2-yl)acetamide (5) is a potent inhibitor of TGF beta RI kinase that provides durable antitumor activity when combined with an anti-PD-1 antibody. In order to conduct a full range of preclinical studies, over 150 g of high-quality material was required. The original discovery route through a stepwise copper-mediated Sonogashira reaction, trifluoroacetamide formation, and Cacchi reaction suffered from scale-up issues, mainly associated with tedious chromatographic purification of intermediates. This communication describes a chromatography-free one-pot synthesis of 5 via sequential Sonogashira and Cacchi reactions promoted by the superior catalyst Pd(OAc)(2)/BINAP, which was discovered by catalyst screening.
引用
收藏
页码:454 / 458
页数:5
相关论文
共 50 条
  • [41] Crystal structure of 1,5-di(pyridin-2-yl)-3-(pyridin-4-yl)-pentane-1,5-dione, C20H17N3O2
    Liu, Jun-Na
    Lou, Xin-Hua
    Zhao, Shuang
    Zhang, Yu-Qing
    Deng, Rui-Xue
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2010, 225 (04): : 793 - 794
  • [42] (2E)-3-(3-Bromo-4-methoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one
    Jasinski, Jerry P.
    Butcher, Ray J.
    Samshuddin, S.
    Narayana, B.
    Yathirajan, H. S.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O352 - U495
  • [43] (2E)-1-(Pyridin-2-yl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one
    Fun, Hoong-Kun
    Chantrapromma, Suchada
    Suwunwong, Thitipone
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2789 - +
  • [44] 1-[3-(Anthracen-9-yl)-5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
    Zhang, Shi-Lu
    Huang, Kun
    Qin, Da-Bin
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1370 - +
  • [45] Crystal structure of 1-(2-(pyridin-2-yl)-5-(pyridin-3-yl)-1,3,4-oxadiazol-3(2H)-yl)ethan-1-one, C14H12N4O2
    Yu, Xiang
    Huang, Ling
    Zhou, Xing-Ji
    Chen, Ya-Fang
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (05): : 1065 - 1066
  • [46] Synthesis of 2-Chloro-N-(4-(6-chloroH-imidazo[1,2-a]pyridin-2-yl)phenyl) Acetamide Derivatives as Antitubercular Agents
    Nadaf, AfraQuasar A.
    Gaonkar, Supreet
    Mantur, Shivaraj
    Najare, Mahesh S.
    Yaseen, Mohammed
    Sunagar, Manjunath G.
    Joshi, Shrinivas
    Khazi, Imtiyaz Ahmed M.
    CHEMISTRYSELECT, 2020, 5 (45): : 14422 - 14429
  • [47] Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity
    Aliabadi, Alireza
    Mohammadi-Farani, Ahmad
    Roodabeh, Sahar
    Ahmadi, Farahnaz
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (01): : 165 - 172
  • [48] 2-(5-{6-[5-(Pyrazin-2-yl)-1H-1,2,4-triazol-3-yl]pyridin-2-yl}-1H-1,2,4-triazol-3-yl)pyrazine
    Xu, Zhouqing
    Sun, Yanchun
    Wang, Qiang
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2457 - U1394
  • [49] Reaction of N-fluoropyridinium fluoride with isonitriles and diazo compounds:: a one-pot synthesis of (pyridin-2-yl)-1H-1,2,3-triazoles
    Kiselyov, AS
    TETRAHEDRON LETTERS, 2006, 47 (15) : 2631 - 2634
  • [50] Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines
    Bahekar, Rajesh H.
    Jain, Mukul R.
    Goel, Ashish
    Patel, Dipam N.
    Prajapati, Vijay M.
    Gupta, Arun A.
    Patel, Pankaj R.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (09) : 3248 - 3265